0R2M.L Reddit Mentions

Track 0R2M.L's AI-powered predictions, market trends, and investment insights.

0R2M.L AI Prediction 0R2M.L Sentiment 0R2M.L StockTwits

Mock Tradesimulated, no real money

You don't hold 0R2M.L in your mock portfolio yet.

0R2M.L Reddit Mentions

Track 0R2M.L's AI-powered predictions, market trends, and investment insights.

0R2M.L AI Prediction 0R2M.L Sentiment 0R2M.L StockTwits

Reddit Mentions

0R2M.L has been mentioned an estimated 0 times on Reddit over the last 24 hours.

Daily Change—
1 Month Change—
3 Month Change—

Evidence Stack

What Changed?

Key moves vs recent baseline (last day / last week)

Price (1d)-0.0%

Price (7d)-3.4%

Volume vs avg+2.6x

Reddit mentions vs 7D++50%

Volatility vs normal1.3x

Why Now?

Plain-English summary of the biggest drivers (informational)

Risk Flags

Potential risk factors to review

Low liquidity

Avg volume 0K — may be hard to exit

Based on earnings timing, volatility, liquidity and crowd activity. Informational signals only — not investment advice.

Invalidation Signals

Reassess your thesis if any of these occur:

Price breaks below ~$600.66 (recent support level)

Upgrade to see the full Evidence Stack

What Changed, Why Now, and Risk Flags — available on the Investor plan and above

Get Started

0R2M.L AI Stock Analysis

Financial Performance

bullish

Regeneron’s valuation and earnings profile look attractive relative to its recent price action. A low PE ratio of 8.87 combined with very high EPS of 70.31 suggests strong underlying profitability and cash‑generation capacity that the market may not be fully pricing in. Absent evidence of a structural earnings decline, these metrics tilt fundamentally bullish.

Low PE ratio (8.87) versus a historically profitable, established biotech indicates the stock is priced conservatively relative to current earnings power.
High EPS of 70.31 implies robust net income and strong per‑share profitability, providing a margin of safety against cyclical or pipeline volatility.
The disconnect between strong earnings metrics and a sharply lower share price suggests potential mispricing if earnings are sustainable, supporting a fundamentally bullish stance.

Stock Price & Technicals

bearish

Technically, Regeneron is in a weak position despite solid fundamentals. The stock is down 10.2% over the last month, trades well below its 200‑day moving average of $834.06 at $623.75, and the RSI of 36.85 signals lingering downside or at least a lack of strong buying interest. Trend and momentum indicators are currently bearish, even if approaching early oversold territory.

Price at $623.75 is significantly below the 200‑day moving average of $834.06, indicating a pronounced intermediate‑term downtrend and technical overhead resistance.
A 10.2% decline over the last month reflects negative momentum and suggests recent sentiment has turned against the stock.
RSI at 36.85 is below neutral (50) but not yet deeply oversold (<30), pointing to weak momentum with some risk of further downside before a decisive reversal.

Alternative Data Signals

bullish

Alternative data points lean constructive on Regeneron’s business trajectory. A 40.4% month‑over‑month increase in job openings and stable to growing social media presence (especially on Instagram and Facebook) suggest active investment in growth and sustained brand engagement. Web traffic at ~286k monthly visitors is meaningful and, combined with hiring, implies ongoing operational activity rather than contraction.

Job openings at 629, up 40.4% month over month, are a strong positive signal that the company is investing in expansion, R&D, and/or commercialization rather than cutting back.
Social media footprint is broad and largely stable or growing: Instagram followers up 13.4%, modest growth on Facebook and YouTube, and a large LinkedIn base (656,139) indicating strong professional and recruiting reach.
Flat or slightly positive follower trends on most platforms and steady web traffic (286,422 visitors/month) suggest no obvious deterioration in public or professional interest, aligning more with a growth or steady‑state narrative than a contractionary one.

Conclusion

neutral

Regeneron’s fundamentals and alternative data profile appear supportive, but the stock is technically weak in the near term. Strong earnings (high EPS, low PE) and expansionary hiring contrast with a sharp price decline and a downtrend well below the 200‑day moving average. Overall, the setup looks neutral: fundamentally and operationally constructive, but with bearish technicals that may cap upside until sentiment and momentum improve.

Fundamentals and alternative data (profitability metrics, hiring growth, and stable/growing digital presence) skew bullish and suggest the business remains healthy.
Technical indicators (recent price drop, sub‑200‑day trading level, and weak RSI) are bearish, implying near‑term downside or volatility risk despite longer‑term strength.

AI Score

Hold

Alternative5

Fundamental6

Technical5

Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.

Mock Tradesimulated, no real money

You don't hold 0R2M.L in your mock portfolio yet.